Abstract
BACKGROUND: Diet may impact important risk factors for endometrial cancer such as obesity and inflammation. However, evidence on the role of specific dietary factors is limited. We investigated associations between dietary fatty acids and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
METHODS: This analysis includes 1,886 incident endometrial cancer cases and 297,432 non-cases. All participants were followed up for a mean of 8.8 years. Multivariable Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) of endometrial cancer across quintiles of individual fatty acids estimated from various food sources quantified through food frequency questionnaires in the entire EPIC cohort. The false discovery rate (q-values) was computed to control for multiple comparisons.
RESULTS: Consumption of n-6 γ-linolenic acid was inversely associated with endometrial cancer risk (HR comparing 5th with 1st quintile Q5-Q1=0.77, 95% CI = 0.64; 0.92, p trend=0.01, q-value = 0.15). This association was mainly driven by γ-linolenic acid derived from plant sources (HR per unit increment=0.94, 95%CI= (0.90;0.98), p = 0.01) but not from animal sources (HR per unit increment= 1.00, 95%CI = (0.92; 1.07), p = 0.92). In addition, an inverse association was found between consumption of n-3 α-linolenic acid from vegetable sources and endometrial cancer risk (HR per unit increment= 0.93, 95%CI = (0.87; 0.99), p = 0.04). No significant association was found between any other fatty acids (individual or grouped) and endometrial cancer risk.
CONCLUSION: Our results suggest that higher consumption of γ-linolenic acid and α-linoleic acid from plant sources may be associated with lower risk of endometrial cancer.
| Original language | English |
|---|---|
| Article number | 159 |
| Pages (from-to) | 1-12 |
| Journal | BMC Cancer |
| Volume | 23 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 16 Feb 2023 |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Funding
The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London which has additional infrastructure support provided by the NIHR Imperial Biomedical Research Centre (BRC). The national cohorts are supported by: Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education Nationale, Institut National de la Santé et de la Recherche Médicale (INSERM) (France); German Cancer Aid, German Cancer Research Center (DKFZ), German Institute of Human Nutrition PotsdamRehbruecke (DIfE), Federal Ministry of Education and Research (BMBF) (Germany); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, Compagnia di SanPaolo and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF), Statistics Netherlands (The Netherlands); Health Research Fund (FIS) - Instituto de Salud Carlos III (ISCIII), Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology - ICO (Spain); Swedish Cancer Society, Swedish Research Council and County Councils of Skåne and Västerbotten (Sweden); Cancer Research UK (C864/A 14136 to EPIC-Norfolk (DOI https://doi.org/10.22025/2019.10.105.00004 ); C8221/A29017 to EPIC-Oxford), Medical Research Council (MR/N003284/1 and MC_UU_00006/1 to EPIC-Norfolk; MR/M012190/1 to EPIC-Oxford). (United Kingdom). We would like to thank ‘the National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands’ for their contribution and ongoing support to the EPIC Study. This work was undertaken during the tenure of a doctoral Fellowship supported by INCa (INCa 2016 − 184), by Fondation ARC pour la recherche sur le cancer (ARC 2019-DOC4) and by IARC.
| Funders | Funder number |
|---|---|
| Catalan Institute of Oncology - ICO | |
| Compagnia di SanPaolo | |
| County Councils of Skåne | |
| Department of Epidemiology and Biostatistics | |
| Dutch Prevention Funds | |
| Dutch ZON (Zorg Onderzoek Nederland | |
| FIS | |
| German Institute of Human Nutrition PotsdamRehbruecke | |
| Health Research Fund | |
| LK Research Funds | |
| NKR | |
| National Institute for Public Health and the Environment | |
| Netherlands Cancer Registry | |
| Kræftens Bekæmpelse | |
| Deutsches Krebsforschungszentrum | |
| Centre International de Recherche sur le Cancer | |
| National Research Council | |
| University of Maryland School of Public Health | |
| Cancer Research UK | |
| World Cancer Research Fund | |
| Imperial College London | |
| Institut national de la santé et de la recherche médicale | |
| Bundesministerium für Bildung und Forschung | |
| Cancerfonden | |
| Ministerie van Volksgezondheid, Welzijn en Sport | |
| Fondation ARC pour la Recherche sur le Cancer | ARC 2019-DOC4 |
| Ligue Contre le Cancer | |
| Vetenskapsrådet | |
| Instituto de Salud Carlos III | |
| Associazione Italiana per la Ricerca sul Cancro | |
| Deutsche Krebshilfe | |
| Rijksinstituut voor Volksgezondheid en Milieu | |
| Institut Gustave-Roussy | |
| Mutuelle Générale de l'Education Nationale | |
| Consejería de Salud y Familias, Junta de Andalucía | |
| NIHR Imperial Biomedical Research Centre |
Keywords
- Diet
- Endometrial cancer
- Epidemiology
- Fatty acids